logo

Novavax Inc. (NVAX)



Trade NVAX now with
  Date
  Headline
5/9/2022 4:05:54 PM Novavax Q1 EPS $2.56 Vs. Loss $3.05 Year Ago
5/9/2022 4:05:44 PM Novavax Inc. Q1 Earnings Summary
4/22/2022 7:01:33 AM Novavax Begins COVID-19 Vaccine Booster Study In Adolescents In Phase 3 PREVENT-19 Trial
4/20/2022 1:35:03 PM Novavax Announces Initial Results From Phase 1/2 Clinical Trial Of Its COVID-Influenza Combination Vaccine
4/19/2022 7:18:16 AM Novavax Announces Approval Of Nuvaxovid COVID-19 Vaccine For Primary And Booster Immunization In Japan
4/18/2022 10:00:02 AM Novavax : Data On COVID-19 Influenza Combination Vaccine &seasonal Influenza Vaccine To Be Presented
4/8/2022 9:02:21 AM Novavax, Serum Institute Of India Receive Emergency Use Authorization For COVID-19 Vaccine In Thailand
3/31/2022 6:02:01 AM Novavax Submits Request To Expand Conditional Marketing Authorization Of COVID-19 Vaccine In EU To Adolescents
3/25/2022 8:32:06 AM Novavax Reports Participation In Two Booster Studies Using Its COVID-19 Vaccine